Cyclodextrins and other enhancers in rectal delivery

Enhancement in Drug Delivery

Volumn , Issue , 2006, Pages 147-172

  Arima, Hidetoshi ^a   Uekama, Kaneto ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886494514     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (168)

1. de Boer, A.G., et al. 1982. Rectal drug administration: Clinical pharmacokinetic considerations. Clin Pharmacokinet 7:285.
2. van Hoogdalem, E., A.G. de Boer, and D.D. Breimer. 1991. Pharmacokinetics of rectal drug administration. Part I. General considerations and clinical applications of centrally acting drugs. Clin Pharmacokinet 21:11.
3. Song, Y., et al. 2004. Mucosal drug delivery: Membranes, methodologies, and applications. Crit Rev Ther Drug Carrier Syst 21:195.
4. Sayani, A.P., and Y.W. Chien. 1996. Systemic delivery of peptides and proteins across absorptive mucosae. Crit Rev Ther Drug Carrier Syst 13:85.
5. Lee, V.H. 1988. Enzymatic barriers to peptide and protein absorption. Crit Rev Ther Drug Carrier Syst 5:69.
6. Uekama, K., and M. Otagiri. 1987. Cyclodextrins in drug carrier systems. Crit Rev Ther Drug Carrier Syst 3:1.
7. Szejtli, J. 1994. Medicinal applications of cyclodextrins. Med Res Rev 14:353.
8. Matsuda, H., and H. Arima. 1999. Cyclodextrins in transdermal and rectal delivery. Adv Drug Deliv Rev 36:81.
9. Thompson, D.O. 1997. Cyclodextrins-enabling excipients: Their present and future use in pharmaceuticals. Crit Rev Ther Drug Carrier Syst 14:1.
10. Albers, E., and B.W. Muller. 1995. Cyclodextrin derivatives in pharmaceutics. Crit Rev Ther Drug Carrier Syst 12:311.
11. Stella, V.J., and R.A. Rajewski. 1997. Cyclodextrins: Their future in drug formulation and delivery. Pharm Res 14:556.
12. Uekama, K. 2004. Design and evaluation of cyclodextrin-based drug formulation. Chem Pharm Bull 52:900.
13. Szente, L., et al. 1985. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies. Pharmazie 40:406.
14. Celebi, N., M. Iscanoglu, and T. Degim. 1991. The release of naproxen in fatty suppository bases by b-cyclodextrin complexation. Pharmazie 46:863.
15. Iwaoku, R., et al. 1982. Enhanced absorption of phenobarbital from suppositories containing phenobarbital-b-cyclodextrin inclusion complex. Chem Pharm Bull 30:1416.
16. Otagiri, M., et al. 1983. Improvements to some pharmaceutical properties of flurbiprofen by b- and g-cyclodextrin complexations. Acta Pharm Suec 20:1.
17. Kikuchi, M., F. Hirayama, and K. Uekama. 1987. Improvement of oral and rectal bioavailability of carmofur by methylated b-cyclodextrin complexations. Int J Pharm 38:191.
18. Uekama, K., et al. 1986. Possible utility of b-cyclodextrin complexation in the preparation of biphenyl acetic acid suppositories. Yakugaku Zasshi 106:1126.
19. Frijlink, H.W., A.J.M. Schoonen, and C.F. Lerk. 1980. The cyclodextrins on drug release from fatty suppository bases. In-vitro observations, ed. H.W. Frijlink, 77. Groningen: Drukkerij van denderen.
20. Uekama, K., et al. 1985. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-b-cyclodextrin. J Pharm Sci 74:841.
21. Arima, H., T. Kondo, and T. Irie. 1992. Use of water-soluble b-cyclodextrin derivatives as carriers of anti-inflammatory drug biphenyl-acetic acid in rectal delivery. Yakugaku Zasshi 112:65.
22. Frijlink, H.W., et al. 1992. The effects of cyclodextrins on drug release from fatty suppository bases. III. Application of cyclodextrin derivatives. Eur J Pharm Biopharm 38:174.
23. Arima, H., et al. 1992. Enhanced rectal absorption and reduced local irritation of the antiinflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble b-cyclodextrin derivatives and formulation as oleaginous suppository. J Pharm Sci 81:1119.
24. Frijlink, H.W., et al. 1991. The effects of cyclodextrins on drug release from fatty suppository bases. II. In-vivo observations. Eur J Pharm Biopharm 37:183.
25. Takahashi, T., et al. 1986. Stabilization of AD-1590, a non-steroidal antiinflammatory agent, in suppository bases by b-cyclodextrin complexation. Chem Pharm Bull 34:1770.
26. Kondo, T., T. Irie, and K. Uekama. 1996. Combination effects of a-cyclodextrin and xanthan gum on rectal absorption and metabolism of morphine from hollow-type suppositories in rabbits. Biol Pharm Bull 19:280.
27. Rajewski, R.A., and V.J. Stella. 1996. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 85:1142.
28. Irie, T., and K. Uekama. 1999. Cyclodextrins in peptide and protein delivery. Adv Drug Deliv Rev 36:101.
29. Loftsson, T., and J.H. Olafsson. 1998. Cyclodextrins: New drug delivery systems in dermatology. Int J Dermatol 37:241.
30. Loftsson, T., and T. Jarvinen. 1999. Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev 36:59.
31. Watanabe, Y., et al. 1992. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits. Chem Pharm Bull 40:3042.
32. Watanabe, Y., et al. 1996. Pharmacodynamics and pharmacokinetics of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after administration of a rectal dosage vehicle. Biol Pharm Bull 19:1059.
33. Kowari, K., et al. 2002. Pharmacokinetics and pharmacodynamics of human chorionic gonadotropin (hCG) after rectal administration of hollow-type suppositories containing hCG. Biol Pharm Bull 25:678.
34. Nakanishi, K., et al. 1990. Effect of cyclodextrins on biological membrane. I. Effect of cyclodextrins on the absorption of a non-absorbable drug from rat small intestine and rectum. Chem Pharm Bull 38:1684.
35. Yanagi, H., et al. 1991. Effect of inclusion complexation of decanoic acid with a-cyclodextrin on rectal absorption of cefmetazole sodium suppository in rabbits. Yakugaku Zasshi 111:65.
36. Kaji, Y., et al. 1985. Selective transfer of 1-hexylcarbamoyl-5-fluorouracil into lymphatics by combination of b-cyclodextrin polymer complexation and absorption promotor in the rat. Int J Pharm 24:79.
37. Uekama, K., et al. 1995. Modification of rectal absorption of morphine from hollow-type suppositories with a combination of a-cyclodextrin and viscosity-enhancing polysaccharide. J Pharm Sci 84:15.
38. Lin, S.Y., and J.C. Yang. 1990. Effect of b-cyclodextrin on the in vitro permeation rate and in vivo rectal absorption of acetaminophen hydrogel preparations. Pharm Acta Helv 65:262.
39. Irie, T., and K. Uekama. 1997. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 86:147.
40. Miyazaki, I., et al. 1995. Physicochemical properties and inclusion complex formation of dcyclodextrin. Eur J Pharm Sci 3:153.
41. Rothblat, G.H., et al. 1999. Cell cholesterol efflux: Integration of old and new observations provides new insights. J Lipid Res 40:781.
42. Hovgaard, L., and H. Brondsted. 1995. Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins. Pharm Res 12:1328-1332.
43. Costa, S., G. Zinelli, and L. Bufalino. 1990. Piroxicam-b-cyclodextrin in the treatment of dysmenorrhoea. Drug Invest 4:73.
44. Totterman, A.M., et al. 1997. Intestinal safety of water-soluble b-cyclodextrins in paediatric oral solutions of spironolactone: Effects on human intestinal epithelial Caco-2 cells. J Pharm Pharmacol 49:43.
45. Muranishi, S. 1984. Characteristics of drug absorption via the rectal route. Methods Find Exp Clin Pharmacol 6:763.
46. Muranishi, S. 1990. Absorption enhancers. CRC Crit Rev Ther Drug Carrier Syst 7:1.
47. de Boer, A.G., E.J. van Hoogdalem, and D.D. Breimer. 1990. Improvement of drug absorption through enhancers. Eur J Drug Metab Pharmacokinet 15:155.
48. Nakanishi, K., M. Masada, and T. Nadai. 1983. Effect of pharmaceutical adjuvants on the rectal permeability of drugs. II. Effect of Tween-type surfactants on the permeability of drugs in the rat rectum. Chem Pharm Bull 31:3255.
49. Nakanishi, K., et al. 1982. Effect of pharmaceutical adjuvants on the rectal permeability of drugs. I. Effect of pharmaceutical additives on the permeability of sulfaguanidine through the rat rectum. Yakugaku Zasshi 102:1133.
50. Sakai, K., et al. 1986. Contribution of calcium ion sequestration by polyoxyethylated nonionic surfactants to the enhanced colonic absorption of p-aminobenzoic acid. J Pharm Sci 75:387.
51. Hosny, E.A., H.I. Al-Shora, and M.M. Elmazar. 2001. Relative hypoglycemic effect of insulin suppositories in diabetic beagle dogs: Optimization of various concentrations of sodium salicylate and polyoxyethylene-9-lauryl ether. Biol Pharm Bull 24:1294.
52. Ichikawa, K., et al. 1980. Rectal absorption of insulin suppositories in rabbits. J Pharm Pharmacol 32:314.
53. Kosior, A. 2002. Investigation of physical and hypoglycaemic properties of rectal suppositories with chosen insulin. Acta Pol Pharm 59:353.
54. Morimoto, K., T. Iwamoto, and K. Morisaka. 1987. Possible mechanisms for the enhancement of rectal absorption of hydrophilic drugs and polypeptides by aqueous polyacrylic acid gel. J Pharmacobiodyn 10:85.
55. Morimoto, K., et al. 1985. Effect of non-ionic surfactants in a polyacrylic acid gel base on the rectal absorption of [Asu1,7]-eel calcitonin in rats. J Pharm Pharmacol 37:759.
56. Sechter, I., E. Touitou, and M. Donbrow. 1989. The influence of a non-ionic surfactant on rectal absorption of virus particles. Arch Virol 106:141.
57. Muranishi, S. 1985. Modification of intestinal absorption of drugs by lipoidal adjuvants. Pharm Res 2:108.
58. Hirasawa, T., et al. 1985. Promoting mechanism by bile salt related to water absorption in drug rectal absorption. J Pharmacobiodyn 8:211.
59. Shiga, M., et al. 1985. The promotion of drug rectal absorption by water absorption. J Pharm Pharmacol 37:446.
60. Murakami, T., et al. 1984. Effect of bile salts on the rectal absorption of sodium ampicillin in rats. Chem Pharm Bull 32:1948.
61. Ziv, E., et al. 1983. Bile salts facilitate the absorption of heparin from the intestine. Biochem Pharmacol 32:773.
62. Hosny, E.A. 1999. Relative hypoglycemia of rectal insulin suppositories containing deoxycholic acid, sodium taurocholate, polycarbophil, and their combinations in diabetic rabbits. Drug Dev Ind Pharm 25:745.
63. Hosny, E.A., H.I. Al-Shora, and M.M. Elmazar. 2001. Effect of different bile salts on the relative hypoglycemia of witepsol W35 suppositories containing insulin in diabetic beagle dogs. Drug Dev Ind Pharm 27:837.
64. Hosny, E.A., et al. 2003. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients. Boll Chim Farm 142:361.
65. van Hoogdalem, E.J., et al. 1989. Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats. J Pharmacol Exp Ther 251:741.
66. Van Hoogdalem, E.J., et al. 1990. Absorption enhancement of rectally infused insulin by sodium tauro-24,25-dihydrofusidate (STDHF) in rats. Pharm Res 7:180.
67. Karino, A., et al. 1982. Solvent drag effect in drug intestinal absorption. I. Studies on drug and D2O absorption clearances. J Pharmacobiodyn 5:410.
68. Yamamoto, A., et al. 1992. A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit. J Pharmacol Exp Ther 263:25.
69. Murakami, T., et al. 1981. Studies on absorption promoters for rectal delivery preparations. I. Promoting efficacy of enamine derivatives of amino acids for the rectal absorption of b-lactam antibiotics in rabbits. Chem Pharm Bull 29:1998.
70. Murakami, T., et al. 1982. Studies of absorption promoters for rectal delivery preparations. II. A possible mechanism of promoting efficacy of enamine derivatives in rectal absorption. Chem Pharm Bull 30:659.
71. Kamada, A., et al. 1981. Study of enamine derivatives of phenylglycine as adjuvants for the rectal absorption of insulin. Chem Pharm Bull 29:2012.
72. Kim, S., et al. 1983. Effect of enamine derivatives on the rectal absorption of insulin in dogs and rabbits. J Pharm Pharmacol 35:100.
73. Yagi, T., et al. 1983. Insulin suppository: Enhanced rectal absorption of insulin using an enamine derivative as a new promoter. J Pharm Pharmacol 35:177.
74. Nishihata, T., et al. 1985. Enhanced bioavailability of insulin after rectal administration with enamine as adjuvant in depancreatized dogs. J Pharm Pharmacol 37:22.
75. Miyake, M., et al. 1985. Rectal absorption of [Asu1,7]-eel calcitonin in rats. Chem Pharm Bull 33:740.
76. Miyake, M., et al. 1984. Rectal absorption of lysozyme and heparin in rabbits in the presence of non-surfactant adjuvants. Chem Pharm Bull 32:2020.
77. Nishihata, T., and J.H. Rytting. 1997. Absorption-promoting adjuvants: Enhancing action on rectal absorption. Adv Drug Deliv Rev 28:205.
78. Nishihata, T., J.H. Rytting, and T. Higuchi. 1981. Effects of salicylate on rectal absorption of theophylline. J Pharm Sci 70:71.
79. Nishihata, T., J.H. Rytting, and T. Higuchi. 1982. Enhanced rectal absorption of theophylline, lidocaine, cefmetazole, and levodopa by several adjuvants. J Pharm Sci 71:865.
80. Nishihata, T., J.H. Rytting, and T. Higuchi. 1982. Effect of salicylate on the rectal absorption of lidocaine, levodopa, and cefmetazole in rats. J Pharm Sci 71:869.
81. Nishihata, T., et al. 1984. Enhancement of rectal absorption of ampicillin by sodium salicylate in rabbits. Chem Pharm Bull 32:2433.
82. Nishihata, T., et al. 1984. The effects of salicylate on the rectal absorption of phenylalanine and some peptides, and the effects of these peptides on the rectal absorption of cefoxitin and cefmetazole. J Pharm Sci 73:1326.
83. Nishihata, T., et al. 1983. Enhancement of rectal absorption of insulin using salicylates in dogs. J Pharm Pharmacol 35:148.
84. Mizuno, A., M. Ueda, and G. Kawanishi. 1992. Effects of salicylate and other enhancers on rectal absorption of erythropoietin in rats. J Pharm Pharmacol 44:570.
85. Yoshioka, S., L. Caldwell, and T. Higuchi. 1982. Enhanced rectal bioavailability of polypeptides using sodium 5-methoxysalicylate as an absorption promoter. J Pharm Sci 71:593.
86. Nishihata, T., et al. 1981. Enhanced rectal absorption of insulin and heparin in rats in the presence of non-surfactant adjuvants. J Pharm Pharmacol 33:334.
87. Nishihata, T., et al. 1986. Rectal absorption and lymphatic uptake of Ara-C in rats. Int J Pharm 31:185.
88. West, G.B. 1982. Rectal absorption of dextran in rats in the presence of salicylates. Int Arch Allergy Appl Immunol 68:283.
89. Hosny, E., et al. 1994. Effect of sodium salicylate on insulin rectal absorption in humans. Arzneimittelforschung 44:611.
90. Hauss, D.J., and H.Y. Ando. 1988. The influence of concentration of two salicylate derivatives on rectal insulin absorption enhancement. J Pharm Pharmacol 40:659.
91. Hauss, D.J., et al. 1991. The relationship of salicylate lipophilicity to rectal insulin absorption enhancement and relative lymphatic uptake. J Pharmacobiodyn 14:139.
92. Kajii, H., et al. 1985. Fluorescence study on the interaction of salicylate with rat small intestinal epithelial cells: Possible mechanism for the promoting effects of salicylate on drug absorption in vivo. Life Sci 37:523.
93. Kajii, H., et al. 1986. Effects of salicylic acid on the permeability of the plasma membrane of the small intestine of the rat: A fluorescence spectroscopic approach to elucidate the mechanism of promoted drug absorption. J Pharm Sci 75:475.
94. van Hoogdalem, E.J., A.G. de Boer, and D.D. Breimer. 1986. Influence of salicylate and anaesthesia on the rectal absorption of theophylline in rats. Pharm Weekbl Sci 8:281.
95. Nakanishi, K., et al. 1984. Effect of nonsteroidal anti-inflammatory drugs on the permeability of the rectal mucosa. Chem Pharm Bull 32:1956.
96. Nakanishi, K., M. Masada, and T. Nadai. 1986. Effect of nonsteroidal anti-inflammatory drugs on the absorption of macromolecular drugs in rat rectum. Chem Pharm Bull 34:2628.
97. Nakanishi, K., et al. 1994. Improvement of the rectal bioavailability of latamoxef sodium by adjuvants following administration of a suppository. Biol Pharm Bull 17:1496.
98. Nakanishi, K., et al. 1984. Mechanism of the enhancement of rectal permeability of drugs by nonsteroidal anti-inflammatory drugs. Chem Pharm Bull 32:3187.
99. van Hoogdalem, E.J., A.G. de Boer, and D.D. Breimer. 1988. Rectal absorption enhancement of rate-controlled delivered ampicillin sodium by sodium decanoate in conscious rats. Pharm Weekbl Sci 10:76.
100. Fujioka, T., et al. 2003. Efficacy of a glycyrrhizin suppository for the treatment of chronic hepatitis C: A pilot study. Hepatol Res 26:10.
101. Sasaki, K., et al. 2003. Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats. Int J Pharm 265:95.
102. Matsumoto, Y., et al. 1989. Rectal absorption enhancement of gentamicin in rabbits from hollow type suppositories by sodium salicylate or sodium caprylate. Drug Des Deliv 4:247.
103. Lennernas, H., et al. 2002. The influence of caprate on rectal absorption of phenoxymethylpenicillin:Experience from an in-vivo perfusion in humans. J Pharm Pharmacol 54:499.
104. Takahashi, H., et al. 1997. The enhancing mechanism of capric acid (C10) from a suppository on rectal drug absorption through a paracellular pathway. Biol Pharm Bull 20:446.
105. Van Hoogdalem, E.J., et al. 1988. Absorption enhancement of rectally infused cefoxitin sodium by medium-chain fatty acids in conscious rats: Concentration-effect relationship. Pharm Res 5:453.
106. Yamazaki, M., et al. 1990. The effect of fatty acids on the rectal absorption of acyclovir in rats. J Pharm Pharmacol 42:441.
107. Takahashi, K., et al. 1994. Pharmacokinetic analysis of the absorption enhancing action of decanoic acid and its derivatives in rats. Pharm Res 11:388.
108. Lindmark, T., et al. 1997. Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate. Pharm Res 14:930.
109. Lindmark, T., et al. 1998. Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: Assessment of molecular weight dependence and demonstration of transport routes. J Drug Target 5:215.
110. Hayashi, M., M. Tomita, and S. Awazu. 1997. Transcellular and paracellular contribution to transport processes in the colorectal route. Adv Drug Deliv Rev 28:191.
111. Hayashi, M., et al. 1999. Physiological mechanism for enhancement of paracellular drug transport. J Control Release 62:141.
112. Ogiso, T., et al. 1991. Enhancement by fatty acids of the rectal absorption of propranolol: In vitro evaluation in the rat. J Pharmacobiodyn 14:385.
113. Onuki, Y., et al. 2000. In vivo effects of highly purified docosahexaenoic acid on rectal insulin absorption. Int J Pharm 198:147.
114. Muranishi, S., N. Muranishi, and H. Sezaki. 1979. Improvement of absolute bioavailability of normally poorly absorbed drugs: Inducement of the intestinal absorption of streptomycin and gentamicin by lipid-bile salt mixed micelles in rat and rabbit. Int J Pharm 2:101.
115. Muranishi, N., et al. 1980. Mechanism for the inducement of the intestinal absorption of poorly absorbed drugs by mixed micelles. I. Effects of various lipid-bile salt mixed micelles on the intestinal absorption of streptomycin in rat. Int J Pharm 4:271.
116. Muranishi, S., H. Yoshikawa, and H. Sezaki. 1979. Absorption of 5-fluorouracil from various regions of gastrointestinal tract in rat. Effect of mixed micelles. J Pharmacobiodyn 2:286.
117. Tokunaga, Y., S. Muranishi, and H. Sezaki. 1978. Enhanced intestinal permeability to macromolecules. I. Effect of monoolein-bile salts mixed micelles on the small intestinal absorption of heparin. J Pharmacobiodyn 1:28.
118. Taniguchi, K., S. Muranishi, and H. Sezaki. 1980. Enhanced intestinal permeability to macromolecules. II. Improvement of the large intestinal absorption of heparin by lipid-surfactant mixed micelles in rat. Int J Pharm 4:219.
119. Yoshikawa, H., H. Sezaki, and S. Muranishi. 1983. Mechanism for selective transfer of bleomycin into lymphatics by a bifunctional delivery system via the lumen of the large intestine. Int J Pharm 13:321.
120. Yoshikawa, H., et al. 1984. A method to potentiate enteral absorption of interferon and selective delivery into lymphatics. J Pharmacobiodyn 7:59.
121. Sekine, M., et al. 1985. Improvement of bioavailability of poorly absorbed drugs. V. Effect of surfactants on the promoting effect of medium chain glyceride for the rectal absorption of b-lactam antibiotics in rats and dogs. J Pharmacobiodyn 8:653.
122. Ogiso, T., et al. 1993. Rectal absorption of acyclovir in rats and improvement of absorption by triglyceride base. Biol Pharm Bull 16:315.
123. Wakatsuki, K., et al. 2005. Effects of irradiation combined with cis-diamminedichloroplatinum (CDDP) suppository in rabbit VX2 rectal tumors. World J Surg 29:388.
124. Yoshikawa, H., K. Takada, and S. Muranishi. 1984. Molecular weight dependence of permselectivity to rat small intestinal blood-lymph barrier for exogenous macromolecules absorbed from lumen. J Pharmacobiodyn 7:1.
125. Yoshikawa, H., et al. 1985. Comparison of disappearance from blood and lymphatic delivery of human fibroblast interferon in rat by different administration routes. J Pharmacobiodyn 8:206.
126. Takada, K., et al. 1986. Effect of administration route on the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles. J Pharmacobiodyn 9:156.
127. Supersaxo, A., W.R. Hein, and H. Steffen. 1991. Mixed micelles as a proliposomal, lymphotropic drug carrier. Pharm Res 8:1286.
128. Yoshikawa, H., K. Takada, and S. Muranishi. 1992. Molecular weight-dependent lymphatic transfer of exogenous macromolecules from large intestine of renal insufficiency rats. Pharm Res 9:1195.
129. Aungst, B.J., and N.J. Rogers. 1988. Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery. Pharm Res 5:305.
130. van Hoogdalem, E.J., et al. 1989. Rectal absorption enhancement of des-enkephalin-g-endorphin (DE g E) by medium-chain glycerides and EDTA in conscious rats. Pharm Res 6:91.
131. van Hoogdalem, E.J., et al. 1989. 3-Amino-1-hydroxypropylidene-1,1-diphosphonate (APD):A novel enhancer of rectal cefoxitin absorption in rats. J Pharm Pharmacol 41:339.
132. Tomita, M., M. Hayashi, and S. Awazu. 1996. Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells. J Pharm Sci 85:608.
133. Mishima, M., et al. 1995. Promotion of rectal absorption of sodium ampicillin by disodium glycyrrhetinic acid 3b-O-monohemiphthalate in rats. Biol Pharm Bull 18:566.
134. Yata, N., et al. 1985. Enhanced rectal absorption of b-lactam antibiotics in rat by monodesmosides isolated from pericarps of Sapindus mukurossi (Enmei-hi). J Pharmacobiodyn 8:1041.
135. Utoguchi, N., et al. 1998. Nitric oxide donors enhance rectal absorption of macromolecules in rabbits. Pharm Res 15:870.
136. Yata, N., et al. 1985. Enhanced rectal absorption of sodium ampicillin by N-acyl derivatives of collagen peptide in rabbits and rats. J Pharm Sci 74:1058.
137. Nishihata, T., and T. Higuchi. 1984. Promoting effect of concanavalin A on transport of sodium cefoxitin and phenol red from rat rectal compartment. Life Sci 34:419.
138. Suzuka, T., et al. 1986. Effects of phenothiazines and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide on rat colonic absorption of cefmetazole. J Pharmacobiodyn 9:460.
139. Nishihata, T., M. Miyake, and A. Kamada. 1984. Study on the mechanism behind adjuvant action of diethylethoxymethylene malonate enhancing the rectal absorption of cefmetazole and lysozyme. J Pharmacobiodyn 7:607.
140. Nishihata, T., et al. 1983. Adjuvant effects of glyceryl esters of acetoacetic acid on rectal absorption of insulin and inulin in rabbits. J Pharm Sci 72:280.
141. Nishihata, T., et al. 1984. Possible mechanism behind the adjuvant action of phosphate derivatives on rectal absorption of cefoxitin in rats and dogs. J Pharm Sci 73:1523.
142. Baumgart, D.C., and A.U. Dignass. 2002. Intestinal barrier function. Curr Opin Clin Nutr Metab Care 5:685.
143. Miyoshi, J., and Y. Takai. 2005. Molecular perspective on tight-junction assembly and epithelial polarity. Adv Drug Deliv Rev 57:815.
144. Van Itallie, C.M., and J.M. Anderson. 2004. The molecular physiology of tight junction pores. Physiology 19:331.
145. Tomita, M., et al. 1988. Enhancement of colonic drug absorption by the paracellular permeation route. Pharm Res 5:341.
146. Matsuzaki, T., et al. 2004. Aquaporins in the digestive system. Med Electron Microsc 37:71.
147. Ono, N., et al. 2001. A moderate interaction of maltosyl-a-cyclodextrin with Caco-2 cells in comparison with the parent cyclodextrin. Biol Pharm Bull 24:395.
148. Marttin, E., J.C. Verhoef, and F.W. Merkus. 1998. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs. J Drug Target 6:17.
149. Singer, S.J., and G.L. Nicolson. 1972. The fluid mosaic model of cell membranes. Science 175:720.
150. Edidin, M. 2003. Lipids on the frontier: A century of cell-membrane bilayers. Nat Rev Mol Cell Biol 4:414.
151. Kajii, H., et al. 1986. Effects of sodium salicylate and caprylate as adjuvants of drug absorption on isolated rat small intestinal epithelial cells. Int J Pharm 33:253.
152. Nishihata, T., et al. 1985. Comparison of the effects of sodium salicylate, disodium ethylenediaminetetraacetic acid and polyoxyethylene-23-lauryl ether as adjuvants for the rectal absorption of sodium cefoxitin. J Pharm Pharmacol 37:159.
153. Tomita, M., et al. 1988. Enhancement of colonic drug absorption by the transcellular permeation route. Pharm Res 5:786.
154. Nishihata, T., et al. 1987. Influence of diethyl maleate-induced loss of thiol on cefmetazole uptake into isolated epithelical cells and on cefmetazole absorption from ileal loop of rats. Chem Pharm Bull 35:2914.
155. Murakami, M., et al. 1988. Intestinal absorption enhanced by unsaturated fatty acids. Inhibitory effect of sulfhydryl modifiers. Biochim Biophys Acta 939:238.
156. Yamamoto, A., and S. Muranishi. 1997. Rectal drug delivery systems-Improvement of rectal peptide absorption by absorption enhancers, protease inhibitors and chemical modification. Adv Drug Deliv Rev 28:275.
157. Nishihata, T., et al. 1987. The synergistic effects of concurrent administration to rats of EDTA and sodium salicylate on the rectal absorption of sodium cefoxitin and the effects of inhibitors. J Pharm Pharmacol 39:180.
158. Takeichi, Y., et al. 1990. Combinative improving effect of increased solubility and the use of absorption enhancers on the rectal absorption of uracil in beagle dogs. Chem Pharm Bull 38:2547.
159. Uchida, T., et al. 2001. Preparation and characterization of insulin-loaded acrylic hydrogels containing absorption enhancers. Chem Pharm Bull 49:1261.
160. Miyake, M., et al. 2004. Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine. J Control Release 99:63.
161. Tomita, M., M. Hayashi, and S. Awazu. 1994. Comparison of absorption-enhancing effect between sodium caprate and disodium ethylenediaminetetraacetate in Caco-2 cells. Biol Pharm Bull 17:753.
162. Murakami, T., et al. 1991. Enhanced rectal and nasal absorption of human epidermal growth factor by combined use of the absorption promoter and the synthetic polymer in rats. Eur J Drug Metab Pharmacokinet Spec No 3:125.
163. Yamamoto, K., A.C. Shah, and T. Nishihata. 1994. Enhanced rectal absorption of itazigrel formulated with polysorbate 80 micelle vehicle in rat: Role of co-administered esterase. J Pharm Pharmacol 46:608.
164. Nishihata, T., et al. 1984. Effect of adjuvants on the rectal absorption and lymphatic uptake of pepleomycin in rats. J Pharmacobiodyn 7:278.
165. Morgan, D.J., et al. 1992. Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo. Int J Clin Pharmacol Ther Toxicol 30:576.
166. Nakajima, T., et al. 1990. Indomethacin sustained-release suppositories containing sugar ester in polyethylene glycol base. Chem Pharm Bull 38:1680.
167. Watanabe, K., et al. 1993. Investigation on rectal absorption of indomethacin from sustainedrelease hydrogel suppositories prepared with water-soluble dietary fibers, xanthan gum and locust bean gum. Biol Pharm Bull 16:391.
168. Miyazaki, S., et al. 1995. Thermally gelling poloxamine Synperonic T908 solution as a vehicle for rectal drug delivery. Biol Pharm Bull 18:1151.